Portal de investigación
- Inicio
- Proyectos de investigación
- Caracterización Molecular de Aislamientos Resistentes a Ceftazidime Avibactam en Enterobacterales y Pseudomonas aeruginosa recolectados en cinco Países de América Latina. Molecular mechanisms leading to ceftazidime-avibactam resistance in Enterobacterales and Pseudomonas aeruginosa collected from five Latin American countries
Caracterización Molecular de Aislamientos Resistentes a Ceftazidime Avibactam en Enterobacterales y Pseudomonas aeruginosa recolectados en cinco Países de América Latina. Molecular mechanisms leading to ceftazidime-avibactam resistance in Enterobacterales and Pseudomonas aeruginosa collected from five Latin American countries
Datos básicos
- Código:
- UEB-2020-586
- Dotación:
- Año incial:
- 2020
- Año final:
- 2024
Objetivos del proyecto
Caracterizar los mecanismos moleculares que confieren resistencia a ceftazidima /avibactam en aislamientos de Enterobacterales y P. aeruginosa recolectados en cinco países latinoamericanos entre 2016 y 2017.
Documentos
- No hay documentos
Participantes
Unidades de investigación
Outputs del proyecto
Actualización sobre la resistencia antimicrobiana en instituciones de salud de nivel III y IV en Colombia entre enero del 2018 y diciembre del 2021.
De La Cadena E; (...); Villegas MV
Article. 10.7705/biomedica.7065. 2023
Antimicrobial Stewardship Programs in Latin America and the Caribbean: A Story of Perseverance, Challenges, and Goals
Restrepo-Arbeláez N; (...); Villegas MV
Review. 10.3390/antibiotics12081342. 2023
Antimicrobial stewardship programs in seven Latin American countries: facing the challenges
Pallares CJ; (...); Villegas MV
Article. 10.1186/s12879-023-08398-3. 2023
Association of COVID-19 coinfection with increased mortality among patients with Pseudomonas aeruginosa bloodstream infection in the Veterans Health Administration system
Hojat LS; (...); Epstein LH
Article. 10.1017/ash.2023.455. 2023
Burnout as a social pathology in nursing professionals: an analysis based on the theory of recognition;
Article. 10.47626/1679-4435-2022-771. 2022
Clinical data from studies involving novel antibiotics to treat multidrug-resistant Gram-negative bacterial infections
Kanj SS; (...); van Duin D
Review. 10.1016/j.ijantimicag.2022.106633. 2022
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter Baumannii Among Patients From Different Global Regions
Wang, MG; (...); Doi, YH
Article. 10.1093/cid/ciad556. 2023
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
Wang M.; (...); Zhang F.
Article. 10.1016/S1473-3099(21)00399-6. 2022
Comparative In Vitro Activity of Ceftolozane/Tazobactam against Clinical Isolates of Pseudomonas aeruginosa and Enterobacterales from Five Latin American Countries
García-Betancur JC; (...); Villegas MV
Article. 10.3390/antibiotics11081101. 2022
Consenso de expertos para el tratamiento antimicrobiano de las infecciones causadas por bacilos gram negativos multirresistentes en pacientes adultos
Álvarez-Moreno C.A.; (...); Rojas S.Y.S.
Article. 10.22354/24223794.1130. 2023
Consensus recommendations based on evidence for abdominal sepsis in the pediatric and adult population of colombia
Oñate J.; (...); Villegas M.
Article. 10.22354/in.v25i4.954. 2021
Dynamics of blaKPC-2 Dissemination from Non-CG258 Klebsiella pneumoniae to Other Enterobacterales via IncN Plasmids in an Area of High Endemicity
Rada AM; (...); Restrepo E
Article. 10.1128/AAC.01743-20. 2020
Early appropriate diagnostics and treatment of MDR Gram-negative infections
Bassetti M; (...); Yu Y
Review. 10.1093/jacamr/dlac089. 2022
Elevated MICs of susceptible antipseudomonal cephalosporins in non-carbapenemase-producing, carbapenem-resistant pseudomonas aeruginosa: Implications for dose optimization
Gill C.M.; (...); Thomson K.
Article. 10.1128/AAC.01204-21. 2021
Gaps and barriers in the implementation and functioning of antimicrobial stewardship programmes: Results from an educational and behavioural mixed methods needs assessment in France, the United States, Mexico and India
Lazure P.; (...); Peloquin S.
Article. 10.1093/jacamr/dlac094. 2022
Gaps and barriers in the implementation and functioning of antimicrobial stewardship programmes: results from an educational and behavioural mixed methods needs assessment in France, the United States, Mexico and India (vol 4, pg dlac094, 2022)
Lazure, P; (...); Peloquin, S
Correction. 10.1093/jacamr/dlad010. 2022
Gaps and barriers in the implementation and functioning of antimicrobial stewardship programmes: results from an educational and behavioural mixed-methods needs assessment in France, the United States, Mexico and India - authors' response
Lazure P; (...); Peloquin S
Letter. 10.1093/jacamr/dlad082. 2023
Genetic Diversity of Multidrug-Resistant Pseudomonas aeruginosa Isolates Carrying blaVIM–2 and blaKPC–2 Genes That Spread on Different Genetic Environment in Colombia
Rada AM; (...); Capataz C
Article. 10.3389/fmicb.2021.663020. 2021
Genomic analysis of ctx-m-group-1-producing extraintestinal pathogenic e. Coli (expec) from patients with urinary tract infections (uti) from colombia
Cadena E.D.L.; (...); Villegas MV
Article. 10.3390/antibiotics9120899. 2020
Global resilience and new strategies needed for antimicrobial stewardship during the COVID-19 pandemic and beyond
Goff D.A.; (...); Sanchez P.J.
Article. 10.1002/jac5.1622. 2022
Identification of mcr-1 Genes and Characterization of Resistance Mechanisms to Colistin in Escherichia coli Isolates from Colombian Hospitals
De La Cadena E; (...); Villegas MV
Article. 10.3390/antibiotics12030488. 2023
Impact of antimicrobial stewardship programs on antibiotic consumption and antimicrobial resistance in four Colombian healthcare institutions
Pallares C; (...); Villegas MV
Article. 10.1186/s12879-022-07410-6. 2022
Microbiological and Clinical Aspects of Raoultella spp.
Appel TM; (...); Villegas MV
Review. 10.3389/fpubh.2021.686789. 2021
Molecular Analysis of Polymyxin Resistance among Carbapenemase-Producing Klebsiella pneumoniae in Colombia
de la Cadena, E; (...); Villegas, MV
Article. 10.3390/antibiotics10030284. 2021
Molecular mechanisms leading to ceftolozane/tazobactam resistance in clinical isolates of Pseudomonas aeruginosa from five Latin American countries
Mojica M.F.; (...); Villegas M.V.
Article. 10.3389/fmicb.2022.1035609. 2022
Molecular Mechanisms of Resistance to Ceftazidime/Avibactam in Clinical Isolates of Enterobacterales and Pseudomonas aeruginosa in Latin American Hospitals
Mojica MF; (...); Villegas MV
Article. 10.1128/msphere.00651-22. 2023
Multicenter, Prospective Validation of a Phenotypic Algorithm to Guide Carbapenemase Testing in Carbapenem-Resistant Pseudomonas aeruginosa Using the ERACE-PA Global Surveillance Program
Gill CM; (...); Nicolau DP
Article. 10.1093/ofid/ofab617. 2022
Rapid Diagnostic Test Value and Implementation in Antimicrobial Stewardship Across Low-to-Middle and High-Income Countries: A Mixed-Methods Review
Moore LSP; (...); Apisarnthanarak A
Note. 10.1007/s40121-023-00815-z. 2023
Section 1. Colombian consensus on the diagnosis and follow-up of invasive aspergillosis and Aspergillus disease in adult and pediatric patients*;
Rivas-Pinedo P.; (...); Pallares C.G.
Article. 10.22354/24223794.1062. 2022
Section 2. Colombian consensus for prophylaxis, treatment and prevention of invasive aspergillosis in adult and pediatric patients*;
Oñate J.M.; (...); Pallares C.G.
Review. 10.22354/24223794.1064. 2022
Section 3. Colombian consensus on the diagnosis and treatment of extrapulmonary aspergillosis in adult patients*;
Oñate J.M.; (...); Pallares C.
Article. 10.22354/24223794.1065. 2022
Section 4. Colombian consensus on the diagnosis and treatment of chronic, saprophytic and/or allergic syndromes associated with Aspergillus spp. in adult and pediatric patients*;
Oñate J.M.; (...); Pallares C.
Article. 10.22354/24223794.1066. 2022
Should ceftriaxone-resistant Enterobacterales be tested for ESBLs? A PRO/CON debate
Villegas, MV, Esparza, G, Reyes, J
Article. 10.1093/jacamr/dlab035. 2021
The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa
Gill C.M.; (...); Nicolau D.P.
Article. 10.1007/s10096-021-04308-0. 2021
The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients
Maraolo, AE; (...); Giacobbe, DR
Article. 10.1007/s40121-021-00408-8. 2021
Campos de estudio
Citar el proyecto
Caracterización Molecular de Aislamientos Resistentes a Ceftazidime Avibactam en Enterobacterales y Pseudomonas aeruginosa recolectados en cinco Países de América Latina. Molecular mechanisms leading to ceftazidime-avibactam resistance in Enterobacterales and Pseudomonas aeruginosa collected from five Latin American countries. (UEB-2020-586). 2020-2024. IP:MARIA VIRGINIA VILLEGAS BOTERO.